Hiperplasia prostática benigna

Por el personal de Mayo Clinic
23 de septiembre de 2026

Investigación

Los investigadores de Mayo Clinic están trabajando para mejorar el diagnóstico y el tratamiento de la hiperplasia prostática benigna. Los estudios que actualmente llevan a cabo los investigadores de Mayo Clinic exploran tecnologías de invasión mínima para tratar la hiperplasia prostática benigna. Esto abarca los tratamientos basados en calor, como la termoterapia transuretral con microondas; dispositivos intersticiales, como la coagulación con terapia con láser intersticial y la ablación transuretral con aguja; la ecografía focalizada de alta intensidad y la termoterapia inducida por agua.

Lea más sobre las investigaciones de la hiperplasia prostática benigna en Mayo Clinic.

Publicaciones

Consulte la lista de publicaciones sobre la hiperplasia prostática benigna de médicos de Mayo Clinic en PubMed, un servicio de la Biblioteca Nacional de Medicina.

  1. Wein AJ, et al., eds. Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Nov. 29, 2022.
  2. Whitley B, et al. Benign prostatic hyperplasia. In: Conn's Current Therapy 2021. Elsevier; 2021. https://www.clinicalkey.com. Accessed Nov. 29, 2022.
  3. Management of benign prostatic hyperplasia/lower urinary tract symptoms (2021). American Urological Association. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline. Accessed Nov. 29, 2022.
  4. McVary K. Clinical manifestations and diagnostic evaluation of benign prostatic hyperplasia. https://www.uptodate.com/contents/search. Accessed Nov. 29, 2022.
  5. Ferri FF. Benign prostatic hyperplasia. In: Ferri's Clinical Advisor 2023. Elsevier; 2023. https://www.clinicalkey.com. Accessed Nov. 29, 2022.
  6. Wein AJ, et al., eds. Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Campbell-Walsh Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Nov. 29, 2022.
  7. Townsend CM Jr, et al. Urologic surgery. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Nov. 29, 2022.
  8. McVary K. Surgical treatment of benign prostatic hyperplasia (BPH). https://www.uptodate.com/contents/search. Accessed Nov. 29, 2022.
  9. AskMayoExpert. Benign prostatic hyperplasia. Mayo Clinic; 2022.
  10. Ami T. Allscripts EPSi. Mayo Clinic. Dec. 20, 2022.
  11. Understanding prostate changes: A health guide for men. National Cancer Institute. https://www.cancer.gov/types/prostate/understanding-prostate-changes. Accessed Nov. 30, 2022.
  12. McVary K. Medical treatment of benign prostatic hyperplasia. https://www.uptodate.com/contents/search. Accessed Nov. 29, 2022.
  13. Lee KS, et al. Effect of climatic parameters on acute urinary retention incidence. LUTS: Lower Urinary Tract Symptoms. 2018; doi:10.1111/luts.12184.
  14. Partin AW, et al., eds. Benign prostatic hyperplasia. In: Campbell Walsh Wein Handbook of Urology. Elsevier; 2022. https://www.clinicalkey.com. Accessed Dec. 2, 2022.
  15. Urinary and bladder problems. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/side-effects/urination-changes. Accessed Dec. 2, 2022.
  16. Taneja SS, et al., eds. Complications of endoscopic procedures for benign prostatic hyperplasia. In: Taneja's Complications of Urologic Surgery: Diagnosis, Prevention, and Management. 5th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed Dec. 2, 2022.
  17. Townsend CM Jr, et al. Urologic surgery. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Dec. 2, 2022.
  18. Sandhu JS, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. The Journal of Urology. 2024; doi:10.1097/JU.0000000000003698.
  19. Sapoval M, et al. Prostatic artery embolization versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): A randomized, multicentre, open-label, phase 3, superiority trial. The Lancet Regional Health — Europe. 2023; doi: 10.1016/j.lanepe.2023.100672.
  20. Bilhim T, et al. Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: Single-centre retrospective study in 1072 patients over a 10-year period. Cardiovascular and Interventional Radiology. 2022; doi: 10.1007/s00270-022-03199-8.
  21. Pisco JM, et al. Randomised clinical trial of prostatic artery embolization versus a sham procedure for benign prostatic hyperplasia. European Urology. 2020; doi: 10.1016/j.eururo.2019.11.010.